Cyclin-dependent kinase 5 phosphorylates and induces the degradation of ataxin-2
- 1 March 2014
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 563, 112-117
Abstract
No abstract availableKeywords
Funding Information
- Scientific Research from MEXT of Japan (S.H.)
This publication has 30 references indexed in Scilit:
- Cdk5: a multifaceted kinase in neurodegenerative diseasesTrends in Cell Biology, 2012
- CDK5 Is Essential for Soluble Amyloid β-Induced Degradation of GKAP and Remodeling of the Synaptic Actin CytoskeletonPLOS ONE, 2011
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSNature, 2010
- Quantitative Measurement of in Vivo Phosphorylation States of Cdk5 Activator p35 by Phos-tag SDS-PAGEMolecular & Cellular Proteomics, 2010
- Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin proteinNature Biotechnology, 2010
- Suppression of Mutant Huntingtin Aggregate Formation by Cdk5/p35 through the Effect on Microtubule StabilityJournal of Neuroscience, 2008
- Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cycline‐dependent kinase 5 complexesJournal of Neurochemistry, 2008
- Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and AggregationJournal of Biological Chemistry, 2007
- Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell deathExperimental Neurology, 2007
- Inhibition of Proteasomal Activity Causes Inclusion Formation in Neuronal and Non-Neuronal Cells Overexpressing ParkinMolecular Biology of the Cell, 2003